CD22 and hairy cell leukemia: Hairy cell leukemia (HCL) is a rare hematological malignancy, which is characterized by splenomegaly, hemorrhage, and an accumulation of abnormal B lymphocytes.170 In addition to B-ALL, CD22 also expressed in B cells in HCL and is thus used as a target for treatment.